| | Presentation | Webcast |
|
August 22, 2024Interview Carnegie Investment Bank
| |
|
|
June 4, 2024Presentation - Penser by Carnegie Healthcare Event
| |
|
|
March 26, 2024Live-streamed R&D update regarding Paccal Vet
| |
|
|
February 26, 2024Presentation - Vivesto - Fokuserat och slimmat för en nystart
| |
|
|
November 17, 2023Presentation - Vivesto - Paccal Vet redo för nästa steg
| |
|
|
October 26, 2023Interview Erik Penser Bank
| |
|
|
August 24, 2023Presentation - EPB Bolagsdag
|
|
|
|
May 25, 2023Presentation Erik Penser Bank
|
|
|
|
May 5, 2022Anglonordic Life Science Conference
|
| |
|
March 14, 2022Oasmia Pharmaceutical – Aktiedagen Stockholm
|
|
|
|
January 19, 2022Rights Issue Presentation at Erik Penser Bank
|
| |
|
December 2, 2021Presentation at Stora Aktiedagen Stockholm
|
|
|
|
December 2, 2021Oasmia - Presentation Erik Penser Bank
|
|
|
|
October 21, 2021Interview Erik Penser Bank
| |
|
|
September 29, 2021Naventus LifeScience Summit
|
|
|
|
September 7, 2021Presentation at Aktiedagen Stockholm
|
|
|
|
June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical
| |
|
|
April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
|
| |
|
March 21, 2021BioEurope Spring, Virtual
|
| |
|
March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual
|
| |
|
March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil
|
|
|
|
January 19, 2021SEB Digital Healthcare Seminar Presentation
|
| |
|
December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
|
| |
|
November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference
|
| |
|
October 29, 2020BIO-Europe®, Virtual Conference
|
| |
|
October 7, 2020Oasmia Erik Penser Cancer Day Presentation
|
| |
|
September 24, 2020Oasmia Erik Penser Investor Event Presentation
|
|
|
|
September 21, 2020Presentation at Sachs Biotech in Europe Forum
|
|
|
|
September 15, 2020Aktiedagen Digitalt
|
|
|
|
July 30, 2020Analysguiden: Interview with Oasmia
| |
|
|
June 10, 2020Company Presentation Aktiespararna
|
|
|
|
June 3, 2020Avanza Börsdag
|
|
|
|
May 13, 2020Strategic Review Presentation
|
|
|
|
March 25, 2020Elevar deal
| |
|
|
February 14, 2020Oasmia appoints new CEO
| | |
|
December 3, 2024Swiss Nordic Bio
| |
|
